傳媒專區
傳媒專區 > 媒體報導 > 公院治療癌症自費藥物費用 較市民估計高19倍 組織籲及早規劃 / Citizens unaware of cancer treatment costs

公院治療癌症自費藥物費用 較市民估計高19倍 組織籲及早規劃 / Citizens unaware of cancer treatment costs

21-07-2018

公院治療癌症自費藥物費用 較市民估計高19倍 組織籲及早規劃

 

 
本港公營醫療系統一直被指超出負荷,出現病人輪候時間長、醫護人手不足等問題。在香港,癌症是頭號殺手,每10個死亡的港人,就有3個死於癌症。但有調查發現,港人低估在公立醫院治療癌症費用,逾五成人未有為未來癌症治療開支作準備。

 

香港執業專科醫生協會和病人組織「癌症資訊網」進行了一項調查,分別訪問100名癌症病人及501名非癌症患者。調查發現,受訪港人認為在公立醫院接受癌症治療,所需費用平均為1.35萬元,但癌症患者調查顯示,在公立醫院治療晚期癌症自費藥物費用,平均需付26.7萬元,比普通市民的預計多19倍。

另外,只有約四成人為未來癌症治療開支作準備,但當中約兩成人以強積金或退休金作準備。

組織建議,政府和市民均應儘早開展未來癌症治療規劃,應對日益增加的癌症治療開支。

 

——————————————————————————————————-

Citizens unaware of cancer treatment costs

 

Hongkongers lack awareness of the full cost of getting cancer treatment, according to a survey.

The Cancer Information Hong Kong Charity Foundation interviewed 500 people and asked them how much they thought would be the overall cost of terminal stage colorectal cancer treatment.

The respondents expected the cost of treatment in the vicinity of HK$60,000 on average at public hospitals.

But the actual cost could exceed HK$270,000 and the amount still doesn’t include target therapy and immunotherapy since the Hospital Authority does not offer these services for free.

Poll respondents estimated cancer treatment in private hospitals to cost HK$400,000, but the actual cost is more than three times higher at HK$1.3 million.

Alan Ng Wai-lun, the foundation’s chairman, said more than half of the survey respondents have revealed that they were not setting aside any funds for cancer treatments.

Among the poll respondents, 57 percent said they have prepared for cancer by setting up savings. The rest said they would rely on medical insurance, the Mandatory Provident Fund and financial investments.

Asked what they would do if their insurance cover fails to pay for the costs of cancer treatment, 69 percent of the respondents said they would opt for cheaper public hospital services, and 11 percent said they would sell their apartments to raise funds.

The foundation also surveyed 100 cancer patients and 56 percent of the respondents said they had heard stories about fellow cancer sufferers forced to terminate treatments as they could no longer afford them.

Under the Voluntary Healthcare Insurance Scheme, which will be launched next year, cancer patients can claim a maximum of HK$80,000 for therapies.

Clinical oncology specialist Maverick Tsang Wai-kong said most target therapies cost between HK$30,000 and HK$40,000 per treatment.

Jeffrey Pong Chiu-fai of the Hong Kong Practicing Specialists Association has admitted that cancer services at public hospitals were often fully occupied.

“There are only around 100 clinical oncology specialists under the Hospital Authority and the doctor-patient ratio is one to 2,172,” he said.

 

文章來自: (中) HK01     (Eng) The Standard

 

 

 

疑難排解

會員註冊


或許你會想看
【justwannasay】即使患上癌症,生命並不會就此枯乾;只要堅強地生存下去,也可活出燦爛的人生。
還記得2022年初時疫情非常嚴峻,每天都有過萬人確診新冠,怕打針的我因怕中招最後決定去打防疫針。朋友建議打針前 […]
【justwannasay】難以置信我得了罕有癌症,竟然發生自己身上
大家好!我叫Carol,是一位80年代不煙不酒,沒有家族遺傳史的抗癌女生。 鼻子長期一直鼻敏感的我,沒有特別不 […]
【癌症治療】癌症患者如何面對長期疲勞
  癌症相關疲勞(Cancer-related Fatigue, CRF)是許多癌症存活者在治療期間 […]
港大醫學院全球首個「肝立方」獲日內瓦發明展金獎 為肝癌病人提供最佳治療方案
香港大學李嘉誠醫學院(港大醫學院)科研團隊成功研發「仿生肝立方:肝癌和肝病的全面精準診療平台」(簡稱「肝立方」 […]
【跨境求醫之艱辛跋涉】罕見病續命藥 盼兩地一起買
輪椅代步北上 肌萎女艱辛跋涉求平價藥 香港醫療水平及質素雖然享譽國際,但750萬人口始終是小市場,向藥廠引入進 […]
【新風天域】攜手推動大灣區癌症治療發展 新風天域集團收購香港綜合腫瘤中心
﹝2024年5月23日﹞新風天域集團(以下簡稱新風天域),今天宣佈完成收購領先的綜合性高端私營腫瘤醫療機構—香 […]
【胃癌治療】 「胃癌治療新技術?來聽聽這些多學科專家怎麼說!」活動回顧|抗癌防癌全球視野GCOG
2024年1月27日 北京時間晚上 8 時,由香港大學知識交流辦公室主辦,全球腫瘤協作組(GCOG), 香 港 […]
【鼻咽癌治療】 「鼻咽癌治療新技術?來聽聽這些多學科專家怎麼說!」活動回顧|抗癌防癌全球視野GCOG
香港,2024年2月24日 – 由香港大學知識交流辦公室主辦,全球腫瘤協作組(GCOG)、香港大學 […]
【醫療新知】科技園創科社群逾30創新醫療方案 亮相醫療健康周吸引投資者目光
  科技園創科社群逾30創新醫療方案  亮相醫療健康周吸引投資者目光 公開亮相包括癌症測試及心血管疾 […]
「1+」新機制 兩治癌新藥准在港註冊
特區政府推出「1+」新藥審批機制實施後,已有兩款癌症新藥獲批准在香港註冊,讓更多本地病人受惠。醫院管理局表示, […]
【慈善義賣】母親節曲奇義賣愛心行動
癌症資訊網慈善基金 X 樂行商龍會「母親節曲奇義賣愛心行動」 順利完成! 感謝「樂行商龍會」及其成員、同路人義 […]